Effects of Midodrine and Droxidopa on Splanchnic Capacitance in Autonomic Failure — Stella

Clinical trial discovery in plain English. Data sourced from ClinicalTrials.gov.

ClinicalTrials.gov ↗

Stella is not a medical provider and does not give medical advice. AI-generated summaries are for informational purposes only. Always consult your doctor before making any healthcare decisions.

Effects of Midodrine and Droxidopa on Splanchnic Capacitance in Autonomic Failure — Stella

Recruiting

Back to Autonomic Failure trials

Phase 1 — Early testing in a small group of people (usually 20–80) to evaluate safety, determine safe dosage, and identify side effects.

Trial locations(1 site)

United States

Autonomic Dysfunction Center/ Vanderbilt University Medical Center, Nashville, Tennessee

Key details

Phase

Early testing

Sponsor

Vanderbilt University Medical Center

Enrollment target

~34 participants

Started

September 2016

Primary completion

September 2026

Age range

40 Years – 80 Years

Last updated October 2025

Interested in joining?

Tell us you're interested and we'll help connect you with the research team. We'll never share your email without your permission.

Your name

Email address

Follow this trial

Get notified in plain English when this trial's status changes. No account required.

View full record on ClinicalTrials.gov